+987.9%
MRNA vs SOLS
+37.2%
+950.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SOLS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -6.5% | +19.6% | +12.3% |
| 7D | +20.6% | -8.8% | +29.4% | +19.5% |
| 30D | +27.1% | -0.6% | +27.8% | +27.8% |
| 3M | +353.4% | -9.0% | +362.4% | +361.1% |
| 6M | +446.3% | -28.7% | +474.9% | +464.3% |
| YTD | +776.2% | +19.2% | +757.0% | +684.1% |
| 1Y | +987.9% | +32.6% | +955.3% | +873.5% |
| All | +987.9% | +37.2% | +950.7% | +873.5% |
Cumulative growth
Daily Returns
Daily percentage return beside SOLS.
Daily Out/Under-Performance
Portfolio return minus SOLS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SOLS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SOLS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling